316 related articles for article (PubMed ID: 25905427)
1. Identification of sequence motifs involved in Dengue virus-host interactions.
Asnet Mary J; Paramasivan R; Shenbagarathai R
J Biomol Struct Dyn; 2016; 34(3):676-87. PubMed ID: 25905427
[TBL] [Abstract][Full Text] [Related]
2. Identification of structural motifs in the E2 glycoprotein of Chikungunya involved in virus-host interaction.
Asnet Mary J; Paramasivan R; Tyagi BK; Surender M; Shenbagarathai R
J Biomol Struct Dyn; 2013 Oct; 31(10):1077-85. PubMed ID: 23025271
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
4. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
5. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
6. Epitopes based drug design for dengue virus envelope protein: A computational approach.
Wadood A; Mehmood A; Khan H; Ilyas M; Ahmad A; Alarjah M; Abu-Izneid T
Comput Biol Chem; 2017 Dec; 71():152-160. PubMed ID: 29096381
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
Anasir MI; Ramanathan B; Poh CL
Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
[TBL] [Abstract][Full Text] [Related]
8. Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics.
Parikesit AA; Kinanty ; Tambunan US
Pak J Biol Sci; 2013 Dec; 16(24):1836-48. PubMed ID: 24516999
[TBL] [Abstract][Full Text] [Related]
9. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
10. Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations.
Dubey KD; Tiwari G; Ojha RP
J Mol Model; 2017 Apr; 23(4):102. PubMed ID: 28255859
[TBL] [Abstract][Full Text] [Related]
11. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
12. Target Identification Using Homopharma and Network-Based Methods for Predicting Compounds Against Dengue Virus-Infected Cells.
Hengphasatporn K; Plaimas K; Suratanee A; Wongsriphisant P; Yang JM; Shigeta Y; Chavasiri W; Boonyasuppayakorn S; Rungrotmongkol T
Molecules; 2020 Apr; 25(8):. PubMed ID: 32325755
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.
Frei JC; Kielian M; Lai JR
Virology; 2015 Nov; 485():371-82. PubMed ID: 26339794
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
[TBL] [Abstract][Full Text] [Related]
15. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein.
Amir-Hassan A; Lee VS; Baharuddin A; Othman S; Xu Y; Huang M; Yusof R; Rahman NA; Othman R
J Mol Graph Model; 2017 Jun; 74():273-287. PubMed ID: 28458006
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric analysis of host cell proteins interacting with dengue virus nonstructural protein 1 in dengue virus-infected HepG2 cells.
Dechtawewat T; Paemanee A; Roytrakul S; Songprakhon P; Limjindaporn T; Yenchitsomanus PT; Saitornuang S; Puttikhunt C; Kasinrerk W; Malasit P; Noisakran S
Biochim Biophys Acta; 2016 Sep; 1864(9):1270-1280. PubMed ID: 27108190
[TBL] [Abstract][Full Text] [Related]
17. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.
Limjindaporn T; Wongwiwat W; Noisakran S; Srisawat C; Netsawang J; Puttikhunt C; Kasinrerk W; Avirutnan P; Thiemmeca S; Sriburi R; Sittisombut N; Malasit P; Yenchitsomanus PT
Biochem Biophys Res Commun; 2009 Feb; 379(2):196-200. PubMed ID: 19105951
[TBL] [Abstract][Full Text] [Related]
18. Repurposing of therapeutic antibodies against dengue virus envelope protein receptor binding domain.
Chaudhuri D; Majumder S; Datta J; Giri K
Arch Microbiol; 2024 Jun; 206(7):312. PubMed ID: 38900285
[TBL] [Abstract][Full Text] [Related]
19. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding.
Watterson D; Kobe B; Young PR
J Gen Virol; 2012 Jan; 93(Pt 1):72-82. PubMed ID: 21957126
[TBL] [Abstract][Full Text] [Related]
20. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
Laosutthipong C; Kanthong N; Flegel TW
Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
